Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy
Locations
1
China
Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Start Date
May 30, 2019
Primary Completion Date
May 1, 2021
Completion Date
May 1, 2021
Last Updated
November 1, 2021
NCT04161248
NCT06528301
NCT05940272
NCT06534437
NCT05463263
NCT06609304
Lead Sponsor
Second Affiliated Hospital of Xi'an Jiaotong University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions